Home › Funds › ABG Innovation Capital Partners III GP Ltd › WHWK

ABG Innovation Capital Partners III GP Ltd position in WHWK

WHITEHAWK THERAPEUTICS INC · Health Care

ABG Innovation Capital Partners III GP Ltd reported holding 26,666 shares of WHWK (WHITEHAWK THERAPEUTICS INC) in its Q4 2025 13F filing — a position valued at US$65K, representing 100.00% of its reported portfolio and ranking #1 among its reported holdings. ABG Innovation Capital Partners III GP Ltd has disclosed WHWK holdings in 10 of the last 10 reported quarters, going back to Q3 2023.

Latest position (Q4 2025)26.67K sh
Reported value held$64.53K
Portfolio Weight100.00%
First reportedQ3 2023
Last changeHold
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How ABG Innovation Capital Partners III GP Ltd's WHWK position evolved

ABG Innovation Capital Partners III GP Ltd first disclosed a stake in WHWK in Q3 2023 at 26,666 shares (US$129K). Across 10 filings, ABG Innovation Capital Partners III GP Ltd held the position steady without any share-count change. The most recent filing (Q4 2025) shows 26,666 shares valued at US$65K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 26.67K $129.06K New
Q4 2023 26.67K $53.87K Hold
Q1 2024 26.67K $62.40K Hold
Q2 2024 26.67K $38.93K Hold
Q3 2024 26.67K $54.93K Hold
Q4 2024 26.67K $84.13K Hold
Q1 2025 26.67K $47.47K Hold
Q2 2025 26.67K $49.87K Hold
Q3 2025 26.67K $50.66K Hold
Q4 2025 26.67K $64.53K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WHWK and 13F data

WHWK (WHITEHAWK THERAPEUTICS INC) is a Health Care company. 49 other funds we track also report a position in WHWK — the largest reported positions include Yu Fan (US$22.3M), ACUTA CAPITAL PARTNERS, LLC (US$21.5M), QVT Financial LP (US$21.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WHWK

All WHWK fund holders →

FAQ

How long has ABG Innovation Capital Partners III GP Ltd held WHWK?

ABG Innovation Capital Partners III GP Ltd has disclosed WHWK holdings in 10 of the last 10 reported quarters, going back to Q3 2023.

What is ABG Innovation Capital Partners III GP Ltd's current position in WHWK?

As of Q4 2025, ABG Innovation Capital Partners III GP Ltd holds 26.67K shares of WHWK (WHITEHAWK THERAPEUTICS INC), valued at $64.53K, representing 100.00% of its reported portfolio and ranking #1.

Has ABG Innovation Capital Partners III GP Ltd been buying or selling WHWK?

In the latest 13F filing (Q4 2025), ABG Innovation Capital Partners III GP Ltd held unchanged its position in WHWK.

Which other funds hold WHWK?

Other major institutional holders of WHWK include Yu Fan, ACUTA CAPITAL PARTNERS, LLC, QVT Financial LP, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.